Mangalam Drugs and Organics share news and announcements
NSE: MANGALAMBSE: 532637Pharmaceuticals & BiotechnologySmall Cap
Last close ₹28.65down ₹0.92 (3.11%)BSE ₹28.00
Share price at the NSE close on 23 Oct 2026. Previous close ₹29.57.
52-week range of traded prices to 23 Oct 2026
₹22.80Low, 29 Dec 2025₹71.99High, 23 Oct 2025
- Under NSE's long-term additional surveillance, stage I, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹45 Cr3,423rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 14 May 2026
- 0.4
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 12 Aug 2026
- −30.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- −12.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 14 May 2026
- 1.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 19,55176.4% delivered
Mangalam Drugs and Organics share news and announcements
527 announcements, routine notices left out, newest first. Page 9 of 11.
Jan 2016
Dec 2015
Nov 2015
Oct 2015
Sep 2015
Aug 2015
6 Aug · Board meeting
Jul 2015
Jun 2015
May 2015
5 May · Board meeting
To consider annual audited financial results for the year ended on March 31, 2015.
Apr 2015
Mar 2015
19 Mar · Legal
Price movement : Significant price movement has been observed in Mangalam Drugs And Organics Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Mangalam Drugs And Organics Limited has vide its letter inter-alia stated,"The Company has no pending announcements to make having a bearing on operation/performance of the Company or which may result in unusual price/volume behavior of the stock price."
Feb 2015
5 Feb · Management
Mr. Rajendra Prasad Mimani has resigned as Director from the Board of the Company. The resignation is effective from February 3, 2015.
Jan 2015
14 Jan · Board meeting
Inter-alia to consider and take on record Unaudited Financial results for the Quater ended December 31,2014.
Dec 2014
Nov 2014
4 Nov · Board meeting
Inter-alia to consider and take on record Unaudited Financial results for the Quater ended September 30,2014.3 Nov · Board meeting
At the Board meeting of the Company held on October 31, 2014 inter-alia following matters have been approved by the Board: 1. Re-appointment of Shri. Govardhan M. Dhoot as the Whole time Director of the Company for a period of five years w.e.f. November 01, 2014. 2. Mr. Ajay Samant working with the Company as Vice President (Finance) designated as the Chief Financial Officer pursuant to the requirement under Section 203 of the Companies Act, 2013.
Oct 2014
27 Oct · Management
Mrs. Meenal Sukhani has been appointed as Additional Director on the Board of the Company w.e.f. October 21, 2014. She will be Non - Executive Director of the Company.
Sep 2014
16 Sep · Meeting
Annual General Meeting of the Company will be held on September 29, 2014.3 Sep · Corporate action
Register of Members & Share Transfer Books of the Company will remain closed from September 22, 2014 to September 29, 2014 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the Company.2 Sep · Corporate action
Company has fixed Book Closure from September 22, 2014 to September 29, 2014 for the purpose of Annual General Meeeting.
Aug 2014
1 Aug · Board meeting
Inter Alia to consider and take on record Unaudited Financial Results for the quarter ended June 30, 2014. Further, in accordance with Code of Conduct for Prevention of Insider Trading framed by the Company pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) regulations, 1992, the trading window for dealing in the securities of the Company will be closed for all Directors, officers and designated employees of the Company from July 28, 2014 and would open 24 hours after the announcement of financial results to the public.
Jul 2014
17 Jul · Address Change
Registered office of the Company will be shifting from '292, Princess Street Near Flyover Bridge, Marine Lines, Mumbai- 400020' to '3rd Floor, Rupam Building, 237, P.D. Mello Road, Mumbai-400001, Maharashtra' with effect from the July 21, 2014.
May 2014
21 May · Board meeting
Inter alia, to transact following business: (1) To consider and approve the audited quarterly financial results of the Company for the quarter ended March 31, 2014, the audited financial results of the Company for the financial year ended March 31, 2014. Further in accordance with Code of Conduct for Prevention of Insider Trading framed by the Company pursuant to the Securities and Exchange Board of India (Prohibition of insider Trading) Regulations, 1992, the trading window for dealing in the securities of the Company6 will be closed for all directors, officers and designated employees of the Company from May 15, 2014 and would open 24 hours after announcement of financial result to the public.
Feb 2014
Jan 2014
28 Jan · Board meeting
Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended December 31, 2013.
Nov 2013